EU Approves Novartis AG’s Prexige In Osteoarthritis; Plans To File For U.S. Approval In 2007

November 7, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

ZURICH, Nov 7 (Reuters) - Swiss drugmaker Novartis AG (NOVN.VX: Quote, Profile, Research) said on Tuesday its Prexige painkiller had been approved for use in the European Union for patients with osteoarthritis.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Europe